Entellus introduces Xpress Ultra Multi-Sinus Dilation System

15 February 2015 (Last Updated February 15th, 2015 18:30)

US-based medical technology firm Entellus Medical has introduced the third device in the XprESS family of balloon sinus dilation systems, the XprESS Ultra Multi-Sinus Dilation System.

US-based medical technology firm Entellus Medical has introduced the third device in the XprESS family of balloon sinus dilation systems, the XprESS Ultra Multi-Sinus Dilation System.

XprESS Ultra, with its sleek profile and design, offers precision, versatility and control of the XprESS family of balloon sinus dilation systems.

The profile device provides smooth movement through tight nasal passages and easy endoscopic viewing of the treatment area, while the malleable tip can be reshaped to meet challenges of patients with extremely narrow sinus drainage pathways.

"The profile device provides smooth movement through tight nasal passages and easy endoscopic viewing of the treatment area, while the malleable tip can be reshaped to meet challenges of patients with extremely narrow sinus drainage pathways."

XprESS Ultra provides additional features to address patient needs and meet physician preferences.

Products from the XprESS family are used by ear, nose and throat (ENT) physicians for treatment of patients with symptomatic inflammation of the nasal sinuses, and open narrowed or obstructed sinus drainage pathways using balloon sinus dilation.

Entellus Medical president Robert White said: "The addition of XprESS Ultra to the XprESS family of devices highlights our ongoing commitment to making it even easier for ENT specialists to offer the benefits of balloon sinus dilation to patients suffering from sinusitis."

The company is focused on the design, development and commercialisation of products for the minimally invasive treatment of chronic and recurrent sinusitis patients in the physician office setting or operating room.

When used as a stand-alone therapy, the company's balloon sinus dilation products are the only devices proven in a sufficiently powered prospective, multicentre, randomised, controlled trial to be as effective as functional endoscopic sinus surgery (FESS).